Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLev, Baruch-
dc.contributor.authorRadhakrishnan, Suresh-
dc.contributor.authorCiftci, Mustafa-
dc.date.accessioned2008-06-04T16:12:52Z-
dc.date.available2008-06-04T16:12:52Z-
dc.date.issued2006-03-
dc.identifier.urihttp://hdl.handle.net/2451/27475-
dc.description.abstractWe examine future excess returns, earnings variability and stock volatility of R&D Leaders and Followers. Drawing on the business strategy literature, which makes a clear distinction between R&D Leaders and Followers, we show that R&D Leaders do earn significant future excess returns, while R&D Followers just earn average returns. We further document that R&D Leaders generate higher future sales growth, and return-on-assets than Followers. We also tackle the perennial question of whether the excess returns subsequent to R&D are due to mispricing or risk, and show that only a small part of the returns can be attributed to risk compensation. Finally, it has been documented that R&D expenditures are strongly associated with future earnings volatility, suggesting that R&D is less reliable (verifiable) an asset than physical capital. We show that the association between R&D intensity and future earnings volatility of R&D Leaders is not lower than that of R&D Followers. Thus, penetrating the population of R&D firms to distinguish between R&D Leaders and Followers, we bridge the chasm between the major findings of the economics/finance strand and the accounting body of R&D research.en
dc.language.isoen_USen
dc.relation.ispartofseriesBaruch Lev-15en
dc.titleThe Stock Market Valuation of R&D Leadersen
dc.typeWorking Paperen
Appears in Collections:Accounting Working Papers

Files in This Item:
File Description SizeFormat 
SSRN-id898693.pdf280.82 kBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.